Endoscopic Video-Assisted Nipple-Sparing Mastectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Endoscopic video-assisted nipple-sparing mastectomy (E-NSM): Endoscopic video-assisted nipple-sparing mastectomy (E-NSM) is an advancement in minimally invasive breast surgery designed to reduce surgical trauma and improve cosmetic outcomes while maintaining strict oncologic safety. Recent prospective studies and meta-analyses have shown encouraging results in terms of technical feasibility, reduced flap-related complications, and higher patient satisfaction compared with the conventional open approach.
Study summary
Endoscopic video-assisted nipple-sparing mastectomy (E-NSM) is an advancement in minimally invasive breast surgery designed to reduce surgical trauma and improve cosmetic outcomes while maintaining strict oncologic safety. The procedure will be carried out by a dedicated surgical team in which at least one operator holds certified laparoscopic surgical training issued by a recognized scientific society, ensuring appropriate technical expertise and adherence to surgical safety standards.
Eligibility
Primary outcome measure(s)
- Rate of completion of the procedure endoscopically without conversion to open surgery. — At surgery
Number of procedure not converted to open surgery on the total of study procedures. - Surgery time — At surgery
Average and median duration of endoscopic dissection, including creation of the working space. - Feasibility of immediate reconstruction — At surgery
The feasibility and type of immediate reconstruction performed (direct-to-implant or two stage) measured as the number immediate rescotruction on the number of total surgery performed.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Istituto Europeo di Oncologia | Milan | Italy | Recruiting |
More European Institute of Oncology trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07579117 on ClinicalTrials.gov ↗ ← All trials in Italy